Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice

European Journal of Nutrition

Volumn 55, Issue 3, 2016, Pages 931-940

  Geng, Shanshan ^a   Zhu, Weiwei ^a   Xie, Chunfeng ^a   Li, Xiaoting ^a   Wu, Jieshu ^a   Liang, Zhaofeng ^a   Xie, Wei ^a   Zhu, Jianyun ^a   Huang, Cong ^a   Zhu, Mingming ^a   Wu, Rui ^a   Zhong, Caiyun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Insulin resistance; Medium chain triglyceride; NF B; p38 MAPK

Indexed keywords

CORN OIL; CYCLOOXYGENASE 2; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; LARD; MEDIUM CHAIN TRIACYLGLYCEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; WEIGHT GAIN; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DIET RESTRICTION; DIETARY SUPPLEMENT; GENETICS; METABOLISM; MOUSE MUTANT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CYCLOOXYGENASE 2; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FASTING; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928402908     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0907-0     Document Type: Article

References (49)

1. Li Q, Zhong W, Qiu Y, Kang X, Sun X, Tan X, Zhao Y, Sun X, Jia W, Zhou Z (2013) Preservation of hepatocyte nuclear factor-4alpha contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol Clin Exp Res 37:587–598
2. Shinohara H, Wu J, Aoyama T (2010) Effect of randomly interesterified triacylglycerol containing medium- and long-chain fatty acids on hepatic fatty acid oxidation after a single administration to rats. Biosci Biotechnol Biochem 74:2336–2338
3. Shinohara H, Wu J, Kasai M, Aoyama T (2006) Randomly interesterified triacylglycerol containing medium- and long-chain fatty acids stimulates fatty acid metabolism in white adipose tissue of rats. Biosci Biotechnol Biochem 70:2919–2926
4. Shinohara H, Ogawa A, Kasai M, Aoyama T (2005) Effect of randomly interesterified triacylglycerols containing medium- and long-chain fatty acids on energy expenditure and hepatic fatty acid metabolism in rats. Biosci Biotechnol Biochem 69:1811–1818
5. Takeuchi H, Sekine S, Kojima K, Aoyama T (2008) The application of medium-chain fatty acids: edible oil with a suppressing effect on body fat accumulation. Asia Pac J Clin Nutr 17(Suppl 1):320–323
6. St-Onge MP, Ross R, Parsons WD, Jones PJ (2003) Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 11:395–402
7. St-Onge MP, Jones PJ (2003) Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord 27:1565–1571
8. Nosaka N, Maki H, Suzuki Y, Haruna H, Ohara A, Kasai M, Tsuji H, Aoyama T, Okazaki M, Igarashi O, Kondo K (2003) Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb 10:290–298
9. St-Onge MP, Bosarge A, Goree LL, Darnell B (2008) Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr 27:547–552
10. Bourque C, St-Onge MP, Papamandjaris AA, Cohn JS, Jones PJ (2003) Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women. Metabolism 52:771–777
11. Ronis MJ, Baumgardner JN, Sharma N, Vantrease J, Ferguson M, Tong Y, Wu X, Cleves MA, Badger TM (2013) Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp Biol Med (Maywood) 238:151–162
12. Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, Lange D, Bilski A, Faravelli I, Pasinetti GM (2012) Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One 7:e49191
13. Carlson SJ, Nandivada P, Chang MI, Mitchell PD, O’Loughlin A, Cowan E, Gura KM, Nose V, Bistrian BR, Puder M (2015) The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism 64:274–282
14. Kono H, Fujii H, Ogiku M, Tsuchiya M, Ishii K, Hara M (2010) Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats. Transl Res 156:282–291
15. Mane J, Pedrosa E, Loren V, Ojanguren I, Fluvia L, Cabre E, Rogler G, Gassull MA (2009) Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr 139:603–610
16. Hoshimoto A, Suzuki Y, Katsuno T, Nakajima H, Saito Y (2002) Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br J Pharmacol 136:280–286
17. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
18. Tanti JF, Ceppo F, Jager J, Berthou F (2012) Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne) 3:181
19. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198
20. Tanti JF, Jager J (2009) Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9:753–762
21. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
22. Boisramé-Helms J, Said A, Burban M, Delabranche X, Stiel L, Zobairi F, Hasselmann M, Schini-Kerth V, Toti F, Meziani F (2014) Medium-chain triglyceride supplementation exacerbates peritonitis-induced septic shock in rats: role on cell membrane remodeling. Shock 42:548–553
23. Boisramé-Helms J, Delabranche X, Klymchenko A, Drai J, Blond E, Zobairi F, Mely Y, Hasselmann M, Toti F, Meziani F (2014) Lipid emulsions differentially affect LPS-induced acute monocytes inflammation: in vitro effects on membrane remodeling and cell viability. Lipids 49:1091–1099
24. Terada S, Yamamoto S, Sekine S, Aoyama T (2012) Dietary intake of medium- and long-chain triacylglycerols ameliorates insulin resistance in rats fed a high-fat diet. Nutrition 28:92–97
25. Han JR, Deng B, Sun J, Chen CG, Corkey BE, Kirkland JL, Ma J, Guo W (2007) Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism 56:985–991
26. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621–663
27. Basak S, Hoffmann A (2008) Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 19:187–197
28. Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92:689–737
29. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22:1313–1324
30. Kefaloyianni E, Gaitanaki C, Beis I (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18:2238–2251
31. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM (2011) Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc 70:408–417
32. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Bluher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28:1304–1310
33. Espinola-Klein C, Gori T, Blankenberg S, Munzel T (2011) Inflammatory markers and cardiovascular risk in the metabolic syndrome. Front Biosci (Landmark Ed) 16:1663–1674
34. Tang FY, Pai MH, Chiang EP (2012) Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem 23:1302–1313
35. Park H, Kim M, Kwon GT, Lim do Y, Yu R, Sung MK, Lee KW, Daily JW 3rd, Park JH (2012) A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Mol Carcinog 51:869–880
36. Burgueno AL, Gianotti TF, Mansilla NG, Pirola CJ, Sookoian S (2013) Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1alpha in a rat model. Clin Sci (Lond) 124:53–63
37. Yao L, Herlea-Pana O, Heuser-Baker J, Chen Y, Barlic-Dicen J (2014) Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease. J Immunol Res 2014:181450
38. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4–12
39. Dinh CH, Szabo A, Camer D, Yu Y, Wang H, Huang XF (2015) Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet. Chem Biol Interact 229:1–8
40. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190
41. Lin HL, Shen KP, Chang WT, Lin JC, An LM, Chen IJ, Wu BN (2013) Eugenosedin-A prevents high-fat diet increased adhesion molecules through inhibition of MAPK- and p65-mediated NF-kappaB pathway in rat model. J Pharm Pharmacol 65:300–309
42. Wang Z, Xue L, Guo C, Han B, Pan C, Zhao S, Song H, Ma Q (2012) Stevioside ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by downregulating the NF-kappaB pathway. Biochem Biophys Res Commun 417:1280–1285
43. Liu K, Zhao W, Gao X, Huang F, Kou J, Liu B (2012) Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKbeta and IRS-1 pathways. Atherosclerosis 223:350–358
44. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Jung DY, Ko HJ, Ong H, Kim JK, Mynatt R, Martin RJ, Keenan M, Gao Z, Ye J (2010) Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem 285:4637–4644
45. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103:10741–10746
46. Kuo LH, Tsai PJ, Jiang MJ, Chuang YL, Yu L, Lai KT, Tsai YS (2011) Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia 54:168–179
47. Hemi R, Yochananov Y, Barhod E, Kasher-Meron M, Karasik A, Tirosh A, Kanety H (2011) p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes 60:1134–1145
48. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J (2010) The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 285:29965–29973
49. Xi L, Xiao C, Bandsma RH, Naples M, Adeli K, Lewis GF (2011) C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology 53:127–135